Bremer Bank National Association’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$4.56M Hold
56,179
0.81% 48
2024
Q4
$5.06M Hold
56,179
1% 34
2024
Q3
$5.55M Hold
56,179
1.05% 35
2024
Q2
$5.21M Hold
56,179
1.02% 31
2024
Q1
$5.33M Hold
56,179
0.99% 31
2023
Q4
$5.02M Hold
56,179
0.94% 27
2023
Q3
$4.1M Hold
56,179
0.81% 28
2023
Q2
$4.67M Hold
56,179
0.89% 21
2023
Q1
$4.28M Hold
56,179
0.83% 25
2022
Q4
$4.66M Hold
56,179
0.9% 22
2022
Q3
$4.46M Hold
56,179
0.99% 20
2022
Q2
$4.17M Hold
56,179
0.8% 32
2022
Q1
$5.05M Buy
+56,179
New +$5.19M 0.83% 29

Other funds holding XBI

Bremer Bank National Association's XBI Position: Q1 2025 in Review

Bremer Bank National Association held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2025 at 56,179 shares worth $4.56M. The position accounts for 0.81% of the portfolio, ranked #48.

Bremer Bank National Association first reported a position in XBI in Q1 2022 and has held it in 13 quarters since. The position peaked at $5.55M in Q3 2024. 683 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

  • Bremer Bank National Association held 56,179 shares of State Street SPDR S&P Biotech ETF worth $4.56M as of Q1 2025.
  • Bremer Bank National Association left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2025.
  • State Street SPDR S&P Biotech ETF made up 0.81% of Bremer Bank National Association's portfolio in Q1 2025, its #48 holding.
  • Bremer Bank National Association first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and has held it in 13 quarters since.
  • Bremer Bank National Association's State Street SPDR S&P Biotech ETF position peaked at $5.55M in Q3 2024.
  • 683 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Bremer Bank National Association's 13F filing for Q1 2025, filed 10 Apr 2025.